Evidence map›Paper›PMID 39349948›Full record

ReviewNature reviews. Urology2026

Metaverse in surgery - origins and future potential.

Enrico Checcucci, Alessandro Veccia, Stefano Puliatti, Pieter De Backer, Pietro Piazza, Karl-Friedrich Kowalewski, Severin Rodler, Mark Taratkin, Ines Rivero Belenchon, Loic Baekelandt and 6 more

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. NurseVerse: nursing in the metaverse era.Frontiers in medicine · 2025
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Enrico Checcucci *Department of Surgery, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy. checcu.e@hotmail.it.ORCID 0000-0001-7901-5608
Alessandro VecciaDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Borgo Trento Hospital, Verona, Italy.
Stefano PuliattiDepartment of Urology, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0002-1597-9595
Pieter De BackerDepartment of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Pietro PiazzaDivision of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Karl-Friedrich KowalewskiDepartment of Urology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Severin RodlerDepartment of Urology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Mark TaratkinInstitute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Ines Rivero BelenchonUrology and Nephrology Department, Virgen del Rocío University Hospital, Manuel Siurot s/n, Seville, Spain.
Loic BaekelandtUniversity Hospitals Leuven, Department of Urology, Leuven, Belgium.ORCID 0000-0002-8962-9395
Sabrina De CillisDepartment of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Turin, Italy.
Alberto PianaDepartment of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Turin, Italy.
Ahmed EissaUrology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.ORCID 0000-0001-6817-6887
Juan Gomez RivasDepartment of Urology, Hospital Clinico San Carlos, Madrid, Spain.ORCID 0000-0002-0556-3035
Giovanni Cacciamani *USC Institute of Urology, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-8892-5539
Francesco Porpiglia *Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The metaverse refers to a collective virtual space that combines physical and digital realities to create immersive, interactive environments. This space is powered by technologies such as augmented reality (AR), virtual reality (VR), artificial intelligence (AI) and blockchain. In healthcare, the metaverse can offer many applications. Specifically in surgery, potential uses of the metaverse include the possibility of conducting immersive surgical training in a VR or AR setting, and enhancing surgical planning through the adoption of three-dimensional virtual models and simulated procedures. At the intraoperative level, AR-guided surgery can assist the surgeon in real time to increase surgical precision in tumour identification and selective management of vessels. In post-operative care, potential uses of the metaverse include recovery monitoring and patient education. In urology, AR and VR have been widely explored in the past decade, mainly for surgical navigation in prostate and kidney cancer surgery, whereas only anecdotal metaverse experiences have been reported to date, specifically in partial nephrectomy. In the future, further integration of AI will improve the metaverse experience, potentially increasing the possibility of carrying out surgical navigation, data collection and virtual trials within the metaverse. However, challenges concerning data security and regulatory compliance must be addressed before the metaverse can be used to improve patient care.

Indexed as

Augmented RealitySurgery, Computer-AssistedUrologic Surgical ProceduresVirtual RealityArtificial IntelligenceForecastingHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.